Leiomyosarcoma Clinical Trials in San Diego, CA

Leiomyosarcoma Clinical Trials in San Diego, CA

View the best 10 leiomyosarcoma medical studies in San Diego, California. Access promising new therapies by applying to a San Diego-based Leiomyosarcoma clinical trial.

Trials in San Diego, California

Here are the top 5 medical studies for leiomyosarcoma in San Diego, California

Image of Children's Hospital of Alabama in Birmingham, United States.

Ifosfamide +2 More

Alkylating agents

Recruiting1 awardPhase 2 & 3
This trial is testing whether a new drug called pazopanib, when combined with chemotherapy and radiation, works better for patients with a specific type of soft tissue cancer. Pazopanib helps stop cancer cells from growing, while chemotherapy and radiation kill the cells. The goal is to see if this combination can improve treatment outcomes.
Image of Mayo Clinic Hospital in Arizona in Phoenix, United States.

Talimogene Laherparepvec +1 More

Virus Therapy

Recruiting1 awardPhase 2
This trial is studying the side effects of talimogene laherparepvec and radiation therapy in treating patients with newly diagnosed soft tissue sarcoma.
Image of Children's Hospital of Orange County (Pediatrics [up to 25 years old]) in Orange, United States.

Tabelecleucel

Virus Therapy

Recruiting1 awardPhase 2
This trial tests tabelecleucel, a treatment using special immune cells, in patients with certain diseases related to the Epstein-Barr virus (EBV) who can't use or don't respond to standard treatments. It works by enhancing the immune system's ability to attack virus-infected cells. Tabelecleucel is being tested for recurring or hard-to-treat EBV-related diseases.
Image of The Ottawa Hospital - General Campus in Ottawa, Canada.

Surgery

Recruiting2 awardsPhase 3
This trialtests if chemo before surgery can help people with a certain type of cancer live longer.
Image of Stanford Cancer Center in Stanford, United States.

Nanatinostat +2 More

HDAC inhibitor

Recruiting1 awardPhase 1 & 2
This trial tests a combination of nanatinostat, valganciclovir, and pembrolizumab in patients with certain EBV-related cancers. Nanatinostat makes cancer cells more vulnerable, allowing valganciclovir to kill them, while pembrolizumab boosts the immune system to fight the cancer.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.